Cargando…
Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system
BACKGROUND: Breast cancer is treated with many different modalities, including chemotherapy that can be given as a single agent or in combination. Patients often experience adverse events from chemotherapy during the cycles of treatment which can lead to economic burden. OBJECTIVE: The objective of...
Autores principales: | Rashid, Nazia, Koh, Han A, Baca, Hilda C, Lin, Kathy J, Malecha, Susan E, Masaquel, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063632/ https://www.ncbi.nlm.nih.gov/pubmed/27785099 http://dx.doi.org/10.2147/BCTT.S105618 |
Ejemplares similares
-
Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System
por: Rashid, Nazia, et al.
Publicado: (2015) -
Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens
por: Hansen, Ryan N, et al.
Publicado: (2014) -
Clinical and economic burden of procedural sedation-related adverse events and their outcomes: analysis from five countries
por: Saunders, Rhodri, et al.
Publicado: (2018) -
The Economic Burden of Metastatic Castration Resistant Prostate Cancer and Skeletal Related Events in Japanese University Hospitals
por: Satoh, Takefumi, et al.
Publicado: (2018) -
Particulate Matter Exposure and Preterm Birth: Estimates of U.S. Attributable Burden and Economic Costs
por: Trasande, Leonardo, et al.
Publicado: (2016)